MicroRNA dysregulation in rhabdomyosarcoma: a new player enters the game

Rhabdomyosarcoma (RMS) is the most common of the soft tissue sarcomas with resultant high morbidity, frequently occuring in paediatric patients and young adults. While the molecular basis of RMS has received considerable attention, exact mechanisms underlying its development and metastasis remain unclear. MicroRNAs (miRNAs) are endogenously expressed small non‐coding RNAs that negatively regulate gene expression via translational inhibition or mRNA degradation. Deregulated expression of miRNA has been implicated in initiation, progression, and metastasis of RMS. miRNAs have emerged as key regulators of several physiological and pathophysiological processes and have opened new avenues for diagnosis and treatment of RMS. This review summarizes deregulation and functional roles of miRNAs in RMS and their potential applications for diagnosis, prognosis and treatment of this malignancy. As a rapidly evolving field in basic and translational medicine, it is hopeful that miRNA research will ultimately improve management of RMS.

[1]  Zheng Li,et al.  MicroRNA expression and its clinical implications in Ewing's sarcoma , 2015, Cell proliferation.

[2]  W. Liu,et al.  Targeting the microRNA-21/AP1 axis by 5-fluorouracil and pirarubicin in human hepatocellular carcinoma , 2014, Oncotarget.

[3]  S. Cialfi,et al.  Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members , 2014, BMC Cancer.

[4]  Jianming Xu,et al.  GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis , 2014, Oncotarget.

[5]  Qingqing Liu,et al.  Prediction of signaling pathways involved in enterovirus 71 infection by algorithm analysis based on miRNA profiles and their target genes , 2014, Archives of Virology.

[6]  Zheng Li,et al.  MicroRNAs regulate vascular smooth muscle cell functions in atherosclerosis (review). , 2014, International journal of molecular medicine.

[7]  Chang S. Chan,et al.  MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling , 2014, OncoTarget.

[8]  M. Cieśla,et al.  MicroRNAs and epigenetic mechanisms of rhabdomyosarcoma development. , 2014, The international journal of biochemistry & cell biology.

[9]  S. Varambally,et al.  The miR-124-Prolyl Hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression , 2014, Oncotarget.

[10]  Jianping Chen,et al.  MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin , 2014, Oncotarget.

[11]  U. Ala,et al.  Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma , 2014, Oncogene.

[12]  S. Wang,et al.  TGF-β1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma , 2014, Oncogene.

[13]  Steven Y. Cheng,et al.  MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis , 2014, Oncotarget.

[14]  J. Hung,et al.  Sp1-mediated microRNA-182 expression regulates lung cancer progression , 2014, Oncotarget.

[15]  Jianmin Wang,et al.  Coxsackievirus B3 Engineered To Contain MicroRNA Targets for Muscle-Specific MicroRNAs Displays Attenuated Cardiotropic Virulence in Mice , 2014, Journal of Virology.

[16]  R. Bentley,et al.  Alveolar rhabdomyosarcoma-associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression. , 2014, The Journal of clinical investigation.

[17]  P. Lollini,et al.  Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice , 2013, Oncotarget.

[18]  Jia Yu,et al.  DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer , 2014, Gastric Cancer.

[19]  Jun Zhao,et al.  MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma. , 2014, Oncology research.

[20]  W. Wu,et al.  MicroRNA-10b Promotes Nucleus Pulposus Cell Proliferation through RhoC-Akt Pathway by Targeting HOXD10 in Intervetebral Disc Degeneration , 2013, PloS one.

[21]  G. Wang,et al.  miR-203, a Tumor Suppressor Frequently Down-regulated by Promoter Hypermethylation in Rhabdomyosarcoma* , 2013, The Journal of Biological Chemistry.

[22]  C. Keller,et al.  Mechanisms of impaired differentiation in rhabdomyosarcoma , 2013, The FEBS journal.

[23]  Haorong Wu,et al.  MiR-378 inhibits progression of human gastric cancer MGC-803 cells by targeting MAPK1 in vitro. , 2013, Oncology research.

[24]  Yirong Wang,et al.  Analysis of hsa-miR-30a-5p Expression in Human Gliomas , 2013, Pathology & Oncology Research.

[25]  M. Bonin,et al.  Differential expression of miRNAs in rhabdomyosarcoma and malignant rhabdoid tumor. , 2012, Experimental cell research.

[26]  Burton B. Yang,et al.  Stress Response of Glioblastoma Cells Mediated by miR-17-5p Targeting PTEN and the Passenger Strand miR-17-3p Targeting MDM2 , 2012, Oncotarget.

[27]  A. Mal,et al.  Too much AKT turns PAX3-FKHR dead: A prospect of novel therapeutic strategy for alveolar rhabdomyosarcoma , 2012, Oncotarget.

[28]  N. André,et al.  DICER1 Mutations in embryonal rhabdomyosarcomas from children with and without familial PPB‐tumor predisposition syndrome , 2012, Pediatric blood & cancer.

[29]  Hirotaka Kanzaki,et al.  Novel Direct Targets of miR-19a Identified in Breast Cancer Cells by a Quantitative Proteomic Approach , 2012, PloS one.

[30]  B. Ye,et al.  Mir-373 affects human lung cancer cells' growth and its E-cadherin expression. , 2012, Oncology research.

[31]  Subbaya Subramanian,et al.  Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma , 2012, Laboratory Investigation.

[32]  M. Cieśla,et al.  Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs. , 2012, Antioxidants & redox signaling.

[33]  S. Cameron,et al.  Drosophila and mammalian models uncover a role for the myoblast fusion gene TANC1 in rhabdomyosarcoma. , 2012, The Journal of clinical investigation.

[34]  Xin Zhou,et al.  Expression Levels of MicroRNA-192 and -215 in Gastric Carcinoma , 2012, Pathology & Oncology Research.

[35]  I. Matushansky,et al.  MicroRNAs in chromosomal translocation-associated solid tumors: learning from sarcomas. , 2011, Discovery medicine.

[36]  J. Mei,et al.  Down-Regulated miRNA-214 Induces a Cell Cycle G1 Arrest in Gastric Cancer Cells by Up-Regulating the PTEN Protein , 2011, Pathology & Oncology Research.

[37]  W. Reinhold,et al.  Novel Regulation of Nuclear Factor-YB by miR-485-3p Affects the Expression of DNA Topoisomerase IIα and Drug Responsiveness , 2011, Molecular Pharmacology.

[38]  J. Blay,et al.  miRNA Profiling: How to Bypass the Current Difficulties in the Diagnosis and Treatment of Sarcomas , 2011, Sarcoma.

[39]  Lynette M. Smith,et al.  Genomic and Clinical Analysis of Amplification of the 13q31 Chromosomal Region in Alveolar Rhabdomyosarcoma: A Report from the Children's Oncology Group , 2011, Clinical Cancer Research.

[40]  Subbaya Subramanian,et al.  MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. , 2010, Cancer research.

[41]  H. Hosoi,et al.  Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. , 2010, Biochemical and biophysical research communications.

[42]  H. Lodish,et al.  Distinct roles for miR‐1 and miR‐133a in the proliferation and differentiation of rhabdomyosarcoma cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  O. Delattre,et al.  MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas , 2010, British Journal of Cancer.

[44]  C. Dominici,et al.  RAS signaling dysregulation in human embryonal Rhabdomyosarcoma , 2009, Genes, chromosomes & cancer.

[45]  S. Durinck,et al.  microRNA Profiling Identifies Cancer-Specific and Prognostic Signatures in Pediatric Malignancies , 2009, Clinical Cancer Research.

[46]  J. Qu,et al.  MicroRNA-1/206 Targets c-Met and Inhibits Rhabdomyosarcoma Development* , 2009, The Journal of Biological Chemistry.

[47]  M. Ladanyi,et al.  The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. , 2009, The Journal of clinical investigation.

[48]  A. Donfrancesco,et al.  Deregulated expression of miR-26a and Ezh2 in Rhabdomyosarcoma , 2009, Cell cycle.

[49]  Huating Wang,et al.  NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. , 2008, Cancer cell.

[50]  R. Hoffman,et al.  Imaging of cell trafficking and metastases of paediatric rhabdomyosarcoma , 2008, Cell proliferation.

[51]  Yong-jie Lu,et al.  Role for amplification and expression of glypican-5 in rhabdomyosarcoma. , 2007, Cancer research.